Innovation

Polyclonal Antibodies Against Cardiovirus 2A, 2B, 2C, 3C, 3A, 3B and 3AB Proteins

Wisconsin Alumni Research Foundation (University of Wisconsin)
posted on 06/23/2009

The Wisconsin Alumni Research Foundation (WARF) is seeking commercial partners interested in polyclonal antibodies against several cardiovirus proteins.

Suggested Uses

  • Studying cardiovirus proteins
  • May lead to new means of detecting, preventing and treating cardiovirus infection, including encephalomyocarditis virus infection

Advantages

  • All reagents have been tested for efficacy.
  • Most of the antibodies react with viral precursor proteins, in addition to the mature proteins against which they were raised.
     

Innovation Details
 

Detailed Description

Encephalomyocarditis virus, a cardiovirus, causes encephalitis and myocarditis. It is a widespread problem in swine, causing sudden death and reproductive failure and potentially leading to severe economic losses for pork producers. This virus also infects exotic mammals such as elephants and llamas.

UW-Madison researchers have developed polyclonal mouse antibodies against recombinant cardiovirus proteins. The antibodies can be used for specific molecular recognition of the cardiovirus proteins in vitro or in vivo using experimental techniques such as ELISA (enzyme linked immunosorbent assay), Western assays, protein immunoprecipitation (IP) and confocal fluorescence microscopy.

 

File Number: P07499US 

Other Information:
Aminev A.G., Amineva S.P. & Palmenberg A.C. 2003. Encephalomyocarditis Virus (EMCV) Proteins 2A and 3BCD Localize to Nuclei and Inhibit Cellular mRNA Transcription but not rRNA Transcription. Virus Res. 95, 59-73.

Aminev A.G., Amineva S.P. & Palmenberg A.C. 2003. Encephalomyocarditis Viral Protein 2A Localizes to Nucleoli and Inhibits Cap-Dependent mRNA Translation. Virus Res. 95, 45-57.


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact Emily Bauer at Wisconsin Alumni Research Foundation (University of Wisconsin) for more information.

Request more info via email request more info
People

Case Manager:

Emily Bauer Emily Bauer

Innovations (121)


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Communities
Profile
Related Tags

Find more innovations


February 11, 2009

7,840 members 17,176 innovations 152 organizations

Browse

Dr. Jörg Knäblein – Technology Scouting, Bayer Schering Pharma AG

"Through the iBridge Network, I was able to find a mouse model I was looking for. The collaboration available through the iBridge Network is crucial in driving innovation and I'll continue using it as a valued resource."  read more...